Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in the aftermath of the selloff.
© 2025, . Disclaimer: The part of contents and images are collected and revised from Internet. Contact us ( info@uscommercenews.com) immidiatly if anything is copyright infringed. We will remove accordingly. Thanks!